Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form)

Techniker Krankenkasse Germany has Released a tender for Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form) in Infrastructure and construction. The tender was released on Jan 24, 2025.

Country - Germany

Summary - Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form)

Deadline - Feb 28, 2027

GT reference number - 102134880

Product classification - Construction work

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102134880

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form)local title:: Open-House-Biologika-Rabattverträge 2025-02 - Rituximab (Darreichungsform zur subkutanen Injektion)local description: : Open -House-Biologika-Rabattverträge 2025-02 - Rituximab (Darreichungsform zur subkutanen Injektion)Tender URL: : https://vergabe.tk.de/Satellite/company/login.do?service=https%3A%2F%2Fvergabe.tk.de%2FSatellite%2Fsecured%2FlinkDistribution.do%3Fshow%3Dproject%26pid%3D10518493%26lang%3Dde

Gt Ref Id - 102134880

Deadline - Feb 28, 2027

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database